ESTABLISHMENT OF AN ETOPOSIDE-RESISTANT HUMAN EPITHELIAL TUMOR-CELL LINE INVITRO - CHARACTERIZATION OF PATTERNS OF CROSS-RESISTANCE AND DRUG SENSITIVITIES

被引：30

作者：

HILL, BT

BELLAMY, AS

机构：

来源：

关键词：

D O I：

10.1002/ijc.2910330509

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：599 / 608

页数：10

共 54 条

[1] SOMATIC-CELL MUTATION - DETECTION AND QUANTIFICATION OF X-RAY-INDUCED MUTATION IN CULTURED, DIPLOID HUMAN FIBROBLASTS
ALBERTINI, RJ
DEMARS, R
[J]. MUTATION RESEARCH, 1973, 18 (02): : 199 - 224
[2] ROLE OF DRUG DISPOSITION KINETICS ON CELLULAR TRANSPORT OF ANTI-NEOPLASTIC AGENT VM-26
ALLEN, L
[J]. DRUG METABOLISM REVIEWS, 1978, 8 (01) : 119 - 135
[3] ARNOLD AM, 1982, CANCER CHEMOTH PHARM, V7, P123
[4] FLOW MICROFLUOROMETRIC ESTIMATION OF G1 AND G2 CHALONE INHIBITION OF JB-1 TUMOR-CELL CYCLE INVITRO
BARFOD, NM
[J]. EXPERIMENTAL CELL RESEARCH, 1977, 110 (01) : 225 - 236
[5] BELLAMY AS, 1984, J NATL CANCER I, V72, P411
[6] BELLAMY AS, 1984, UNPUB INFLUENCE FRAC
[7] BENDER RA, 1981, P AM ASSOC CANC RES, V22, P227
[8] BENDER RA, 1981, CANCER CHEMOTHERAPY, P106
[9] UPTAKE AND BINDING OF VINCRISTINE BY MURINE LEUKEMIA-CELLS
BLEYER, WA
FRISBY, SA
OLIVERIO, VT
[J]. BIOCHEMICAL PHARMACOLOGY, 1975, 24 (05) : 633 - 639
[10] BLEYER WA, 1979, P AM SOC CLIN ONCOL, V19, P373